Skip to main content

Beneficial ownership — 13D / 13G

87,281 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
HARRIS ASSOCIATES L P CNH CNH Industrial N.V. 13G/A 12.06% 2y
T. Rowe Price Investment Management, Inc. APLS Apellis Pharmaceuticals, Inc. 13G 5.3% 2y
T. Rowe Price Investment Management, Inc. UTMD Utah Medical Products Inc 13G/A 7.4% 2y
PRICE T ROWE ASSOCIATES INC /MD/ BAH Booz Allen Hamilton Holding Corp 13G/A 7.8% 2y
SILVERCREST ASSET MANAGEMENT GROUP LLC MODV ModivCare Inc. Common Stock 13G 5% 2y
ARMISTICE CAPITAL, LLC ELDN Eledon Pharmaceuticals, Inc. 13G 9.99% 2y
ArrowMark Colorado Holdings LLC MNTV Momentive Global Inc. Common Stock 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. RPID Rapid Micro Biosystems, Inc. 13G/A 0% 2y
Commodore Capital LP CABA Cabaletta Bio, Inc. 13G/A 4.4% 2y
Nantahala Capital Management, LLC ELUT Elutia Inc. 13G 9.9% 2y
ALLIANCEBERNSTEIN L.P. SBFG Sb Financial Group, Inc. 13G/A 8.4% 2y
Venrock Healthcare Capital Partners II, L.P. ANNX Annexon, Inc. 13G/A 1.2% 2y
Caledonia (Private) Investments Pty Ltd TRUE TrueCar, Inc. 13G/A 20.23% 2y
RTW INVESTMENTS, LP ACET Adicet Bio, Inc. 13G/A 9.6% 2y
Joshua Bernstein CBNK Capital Bancorp Inc 13G/A 6.22% 2y
MOORE CAPITAL MANAGEMENT, LP ACAQ Athena Consumer Acquisition Corp. 13G/A 0% 2y
GLAZER CAPITAL, LLC DIST Distoken Acquisition Corporation Ordinary Shares 13G 5.56% 2y
MGF Trust VTEX Vtex 13G/A 28.5% 2y
Jonathan Hyman BRZE Braze, Inc. 13G/A 2.6% 2y
Redmile Group, LLC ANNX Annexon, Inc. 13G/A 9.9% 2y
ALLIANCEBERNSTEIN L.P. EYE National Vision Holdings, Inc. 13G/A 0.1% 2y
Blue Owl Capital Holdings LP LRMR Larimar Therapeutics, Inc. 13G 7.78% 2y
Empyrean Capital Partners, LP AEON AEON Biopharma, Inc. 13G/A 0% 2y
ArrowMark Colorado Holdings LLC CCSI Consensus Cloud Solutions, Inc. 13G/A 13.6% 2y
Alger Associates, Inc. 13-3017981 NTRA Natera, Inc. 13G/A 5.9% 2y
T. Rowe Price Investment Management, Inc. XMTR Xometry, Inc. 13G/A 0% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC CLOE Clover Leaf Capital Corp. Class A Common Stock 13G 5.43% 2y
ALLIANCEBERNSTEIN L.P. PBHC Pathfinder Bancorp, Inc. 13G 5.1% 2y
AQR CAPITAL MANAGEMENT LLC CLRCF ClimateRock 13G/A 1.06% 2y
Dapice Joshua J. FBRX Forte Biosciences, Inc. 13G/A 9.9% 2y
BIOTECHNOLOGY VALUE FUND L P ARAV Aravive, Inc. Common Stock 13G/A 9.99% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SAIA Saia Inc 13G/A 7.4% 2y
MEGACHIPS CORP /FI SITM SITIME Corp 13G/A 20.7% 2y
Technology Crossover Management IX, Ltd. LZ Legalzoom.Com, Inc. 13G/A 8.7% 2y
JANUS HENDERSON GROUP PLC CBAY Cymabay Therapeutics 13G 5.4% 2y
Bradley C. Beasley BBGI Beasley Broadcast Group Inc 13G/A 9.2% 2y
Hood River Capital Management LLC DCGO DocGo Inc. 13G/A 5.87% 2y
SIT INVESTMENT ASSOCIATES INC SRV NXG Cushing Midstream Energy Fund 13G 8.46% 2y
T. Rowe Price Investment Management, Inc. ELMES Elme Communities 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ BPOP Popular, Inc. 13G 5.9% 2y
Caledonia (Private) Investments Pty Ltd RSVR Reservoir Media, Inc. 13G/A 0% 2y
Thomas F. Knight Jr. DNA Ginkgo Bioworks Holdings, Inc. 13G/A 4.1% 2y
Oasis Management Co Ltd. PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share 13G/A 0% 2y
ARMISTICE CAPITAL, LLC STEX Streamex Corp. 13G 6.36% 2y
Newtyn Management, LLC CYT Cyteir Therapeutics, Inc. Common Stock 13G 8.4% 2y
ALLIANCEBERNSTEIN L.P. HP Helmerich & Payne, Inc. 13G/A 0.6% 2y
Langley Steinert CARG CarGurus, Inc. 13G/A 13% 2y
Strategic Value Investors LP WNEB Western New England Bancorp, Inc. 13G/A 5.3% 2y
PRICE T ROWE ASSOCIATES INC /MD/ FWONA Liberty Media Corp 13G/A 3.9% 2y
M3 Funds, LLC SNFCA Security National Financial Corp 13G/A 9% 2y